(Q30459974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

review article

1 reference

title

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

3 October 2019

main subject

0 references

author name string

R D Stevenson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

M L Wolraich

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 October 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Clinics of North America

3 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

1183-1197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

Pemoline-induced Tourette's disorder: a case report

3 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Effects of methylphenidate on reading in children with attention deficit disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

A review of stimulant drug research with hyperactive children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Predicting the response of hyperkinetic children to stimulant drugs: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Do stimulant drugs improve the academic performance of hyperkinetic children? A review of outcome studies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

The Effects of Methylphenidate on the Mother-Child Interactions of Hyperactive Children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Hyperactive children's event-related potentials fail to support underarousal and maturational-lag theories.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Treatment of attention problems with stimulant medication

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Methylphenidate and memory: dissociated effects in hyperactive children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Vicissitudes of follow-up studies: differential effects of parent training and stimulant medication with hyperactives.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Effects of Stimulant Drugs on Academic Performance in Hyperactive and Learning Disabled Children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Gilles de la Tourette's syndrome following methylphenidate administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

The relationship between stimulant medication and tics.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Side effects of dextroamphetamine and methylphenidate in hyperactive children--a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Effect of methylphenidate hydrochloride on stature of hyperactive children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Psychoactive drugs in the immature organism

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Behavioral effects of carbidopa/levodopa in hyperactive boys

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Hyperkinetic behavior syndrome in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Short- and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Stimulant medications precipitate Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Growth of hyperactive children on maintenance regimen of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Drug treatment of hyperactivity in children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Urinary catecholamines and amphetamine excretion in hyperactive and normal boys

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Neurochemical correlates of attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Changes in family function and relationships in children who respond to methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

A change of mind: the Conners abbreviated rating scales reconsidered

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Double-blind assessment of stimulant medication for attention deficit disorder: A model for clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Urinary Monoamine Metabolites in Children with Minimal Brain Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Studies on the hyperactive child. IV. An empirical analysis of the minimal brain dysfunction syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Methylphenidate oral dose plasma concentrations and behavioral response in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Behavior modification therapy in hyperactive children. Research and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Phenylethylamine excretion in attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2936764-5

7 January 2021

10.1016/S0031-3955(16)36764-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2677938%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference